TABLE 5.
Accumulation of mutations in gp120 during passage of CC1/85 in increasing concentrations of maraviroc
Condition | Mutation in gp120a
|
|||||
---|---|---|---|---|---|---|
Domain V2 | Domain V3
|
Domain C3
|
Domain V4
|
|||
Amino acid 163 | Amino acid 316 | Amino acid 319 | Amino acid 323b | Amino acid 355 | Amino acid 405 | |
CC1/85, start | T | A | A ≫ Tc | I ≫ Vd | N ≫ P> K = Ye | S ≫ A > T = E |
Passage 5 (16)f | T | A | A | I | N > P | S |
Passage 9 (32) | T > K | A | A | V | Y > N > S | S ≫ A |
Passage 13 (128) | K > T | T > S | A | V | Y | A |
Passage 15 (2,000) | K | T ≫ S | A > S | V | Y | A ≫ V |
Passage 16 (4,000) | K | T ≫ S | A > S | V | Y | A |
Mutations were identified by sequencing the entire gp160 region of 36 envelope clones amplified from the start virus and 12 envelope clones amplified from the five other time points. Amino acid positions are numbered according to HXB2. Bold font indicates where the majority population carries a change from the prepassage virus.
This could be considered position 322 according to the placement of an insertion in the alignment.
A319T was seen in 4/36 clones.
I323V was seen in 1/36 clones.
N355Y was seen in 1/36 clones.
The concentration [nanomolar] of maraviroc in the selection culture is in parentheses.